| NCT ID | NCT06858982 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Polish Mother Memorial Hospital Research Institute |
| Condition | Hypercholesterolemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-06-01 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The PMMHRI-Pitavastatin Registry is a non-interventional, single-center registry conducted at the Polish Mother's Memorial Hospital Research Institute (PMMHRI). Established in January 2024, the registry enrolls all patients from the Department of Cardiology and Adult Congenital Heart Diseases, the Department of Endocrinology, as well as outpatient cardiology and endocrinology clinics who are prescribed pitavastatin.
Eligibility Criteria
Inclusion Criteria: * patient takling pitavastatin based on the 2021 Polish Lipid Guidelines Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06858982 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypercholesterolemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06858982 currently recruiting?
Yes, NCT06858982 is actively recruiting participants. Contact the research team at maciej.banach@icloud.com for enrollment information.
Where is the NCT06858982 trial being conducted?
This trial is being conducted at Lodz, Poland.
Who is sponsoring the NCT06858982 clinical trial?
NCT06858982 is sponsored by Polish Mother Memorial Hospital Research Institute. The trial plans to enroll 500 participants.